Pricing

OpGen Inc (OPGN)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Oliver Schacht
Employees:
100
9717 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD, 20850
301-869-9683
Stock Split History
DateRatio
2018-01-19 1:25
2019-08-29 1:20
2023-01-05 1:20
OpGen, Inc. engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available